These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7848395)

  • 1. Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.
    Marks RD; Richter JE; Rizzo J; Koehler RE; Spenney JG; Mills TP; Champion G
    Gastroenterology; 1994 Apr; 106(4):907-15. PubMed ID: 7848395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
    Jaspersen D; Schwacha H; Schorr W; Brennenstuhl M; Raschka C; Hammar CH
    J Gastroenterol Hepatol; 1996 Oct; 11(10):900-2. PubMed ID: 8912123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-utility analysis comparing omeprazole with ranitidine in the maintenance therapy of peptic esophageal stricture.
    Stal JM; Gregor JC; Preiksaitis HG; Reynolds RP
    Can J Gastroenterol; 1998; 12(1):43-9. PubMed ID: 9544411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conservative treatment of florid peptic esophageal stenosis. Complete elimination by dilatation and omeprazole in H2-blocker refractory cases].
    Koop H; Katschinski M; Arnold R
    Med Klin (Munich); 1991 Nov; 86(11):566-8. PubMed ID: 1685214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized blinded comparison of omeprazole and ranitidine in the treatment of chronic esophageal stricture secondary to acid peptic esophagitis.
    Silvis SE; Farahmand M; Johnson JA; Ansel HJ; Ho SB
    Gastrointest Endosc; 1996 Mar; 43(3):216-21. PubMed ID: 8857137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus.
    Lundell L
    Digestion; 1992; 51 Suppl 1():49-58. PubMed ID: 1356869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole therapy decreases the need for dilatation of peptic oesophageal strictures.
    Barbezat GO; Schlup M; Lubcke R
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1041-5. PubMed ID: 10468679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis?
    Soga T; Matsuura M; Kodama Y; Fujita T; Sekimoto I; Nishimura K; Yoshida S; Kutsumi H; Fujimoto S
    J Gastroenterol; 1999 Aug; 34(4):435-40. PubMed ID: 10452673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
    Lambert R
    J Gastroenterol Hepatol; 1996 Oct; 11(10):897-9. PubMed ID: 8912122
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized comparative study of omeprazole and famotidine in reflux esophagitis.
    Kawano S; Murata H; Tsuji S; Kubo M; Tatsuta M; Iishi H; Kanda T; Sato T; Yoshihara H; Masuda E; Noguchi M; Kashio S; Ikeda M; Kaneko A
    J Gastroenterol Hepatol; 2002 Sep; 17(9):955-9. PubMed ID: 12167115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group.
    Smith PM; Kerr GD; Cockel R; Ross BA; Bate CM; Brown P; Dronfield MW; Green JR; Hislop WS; Theodossi A
    Gastroenterology; 1994 Nov; 107(5):1312-8. PubMed ID: 7926495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effect of low-dose omeprazole vs. standard-dose ranitidine in mild to moderate reflux esophagitis].
    Kim JW; Kim HS; Lee DK; Suk KT; Kim JM; Baik SK; Kwon SO; Cho MY
    Korean J Gastroenterol; 2004 Mar; 43(3):153-9. PubMed ID: 15034285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole in H2 receptor antagonist-resistant reflux esophagitis.
    Marciano-D'Amore DA; Paterson WG; Da Costa LR; Beck IT
    J Clin Gastroenterol; 1990 Dec; 12(6):616-20. PubMed ID: 1979984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of acid peptic disorders in a managed-care organization.
    Segal R; Russell WL; Ben-Joseph R; Mansheim B
    Clin Ther; 1996; 18(2):319-33; discussion 302. PubMed ID: 8733992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPIs vs H2RAs for erosive reflux esophagitis.
    King VJ
    J Fam Pract; 1998 Mar; 46(3):199-200. PubMed ID: 9519012
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of peptic oesophageal stricture.
    Carr SJ; Wicks AC
    Dig Dis; 1993; 11(4-5):197-205. PubMed ID: 7900938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.